Shanghai Huide Science & TechnologyLtd Past Earnings Performance
Past criteria checks 4/6
Shanghai Huide Science & TechnologyLtd's earnings have been declining at an average annual rate of -15.8%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 14.8% per year. Shanghai Huide Science & TechnologyLtd's return on equity is 5.8%, and it has net margins of 3.1%.
Key information
-15.8%
Earnings growth rate
-15.0%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 14.8% |
| Return on equity | 5.8% |
| Net Margin | 3.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Shanghai Huide Science & Technology Co.,Ltd (SHSE:603192) Investors Are Less Pessimistic Than Expected
Oct 01
Some Investors May Be Worried About Shanghai Huide Science & TechnologyLtd's (SHSE:603192) Returns On Capital
Jul 17Shanghai Huide Science & TechnologyLtd (SHSE:603192) Is Posting Promising Earnings But The Good News Doesn’t Stop There
May 06There's Reason For Concern Over Shanghai Huide Science & Technology Co.,Ltd's (SHSE:603192) Massive 27% Price Jump
Mar 08Revenue & Expenses Breakdown
How Shanghai Huide Science & TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,782 | 87 | 167 | 72 |
| 30 Jun 24 | 2,809 | 76 | 160 | 69 |
| 31 Mar 24 | 2,796 | 66 | 159 | 74 |
| 31 Dec 23 | 2,712 | 64 | 142 | 81 |
| 30 Sep 23 | 2,679 | 51 | 142 | 87 |
| 30 Jun 23 | 2,646 | 51 | 137 | 91 |
| 31 Mar 23 | 2,782 | 54 | 124 | 93 |
| 31 Dec 22 | 3,017 | 62 | 130 | 98 |
| 30 Sep 22 | 3,288 | 91 | 106 | 107 |
| 30 Jun 22 | 3,512 | 104 | 107 | 116 |
| 31 Mar 22 | 3,473 | 113 | 112 | 117 |
| 31 Dec 21 | 3,191 | 118 | 105 | 113 |
| 30 Sep 21 | 2,823 | 144 | 88 | 105 |
| 30 Jun 21 | 2,326 | 138 | 92 | 92 |
| 31 Mar 21 | 1,826 | 132 | 87 | 79 |
| 31 Dec 20 | 1,498 | 124 | 77 | 69 |
| 30 Sep 20 | 1,322 | 101 | 115 | 57 |
| 30 Jun 20 | 1,264 | 108 | 107 | 58 |
| 31 Mar 20 | 1,344 | 124 | 102 | 61 |
| 31 Dec 19 | 1,440 | 132 | 110 | 63 |
| 30 Sep 19 | 1,392 | 126 | 109 | 60 |
| 30 Jun 19 | 1,439 | 122 | 102 | 61 |
| 31 Mar 19 | 1,529 | 118 | 109 | 65 |
| 31 Dec 18 | 1,593 | 115 | 102 | 67 |
| 30 Sep 18 | 1,638 | 116 | 90 | 73 |
| 31 Mar 18 | 1,491 | 100 | 106 | 77 |
| 31 Dec 17 | 1,426 | 110 | 88 | 62 |
| 31 Dec 16 | 1,174 | 98 | 141 | 0 |
| 31 Dec 15 | 1,131 | 53 | 150 | 0 |
| 31 Dec 14 | 1,486 | 47 | 125 | 0 |
Quality Earnings: 603192 has high quality earnings.
Growing Profit Margin: 603192's current net profit margins (3.1%) are higher than last year (1.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 603192's earnings have declined by 15.8% per year over the past 5 years.
Accelerating Growth: 603192's earnings growth over the past year (72.6%) exceeds its 5-year average (-15.8% per year).
Earnings vs Industry: 603192 earnings growth over the past year (72.6%) exceeded the Chemicals industry -5.3%.
Return on Equity
High ROE: 603192's Return on Equity (5.8%) is considered low.